Increased myelinating capacity of embryonic stem cell derived oligodendrocyte precursors after treatment by interleukin-6/soluble interleukin-6 receptor fusion protein. [electronic resource]
Producer: 20060522Description: 387-98 p. digitalISSN:- 1044-7431
- Animals
- Calcium-Binding Proteins
- Cell Culture Techniques -- methods
- Cell Differentiation -- drug effects
- Cell Line
- Cell Shape -- drug effects
- Down-Regulation -- physiology
- Interleukin-6 -- genetics
- Intracellular Signaling Peptides and Proteins
- Mice
- Mice, Neurologic Mutants
- Molecular Sequence Data
- Myelin Basic Protein -- drug effects
- Myelin Sheath -- drug effects
- Nerve Growth Factors -- drug effects
- Nerve Regeneration -- drug effects
- Oligodendroglia -- drug effects
- Organ Culture Techniques
- Receptors, Interleukin-6 -- genetics
- Recombinant Fusion Proteins -- pharmacology
- Stathmin
- Stem Cell Transplantation -- methods
- Stem Cells -- drug effects
- Up-Regulation -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.